Mass‐dependent decline of skeletal muscle function in cancer cachexia
- 21 December 2005
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 33 (5) , 691-693
- https://doi.org/10.1002/mus.20467
Abstract
CD2F1 mice were inoculated with C26 adenocarcinoma cells, followed by assessment of ex vivo muscular function. Muscles from tumor‐bearing mice had a significantly lower force output during a single maximal contraction and during repeated contractions than control muscles. The relative force output, however, did not differ when corrected for muscle mass. Thus, cachexia significantly reduces absolute skeletal muscle function, but muscle “quality” appears unaltered. Muscle Nerve, 2006Keywords
This publication has 10 references indexed in Scilit:
- Cancer‐related fatigueCancer, 2003
- Assessment and management of cancer-related fatigue in adultsThe Lancet, 2003
- Cancer Fatigue: The Way ForwardThe Oncologist, 2003
- Altered expression of skeletal muscle myosin isoforms in cancer cachexiaAmerican Journal of Physiology-Cell Physiology, 2002
- Fatigue in Patients With Breast Cancer Receiving Adjuvant Chemotherapy: A Review of the LiteratureCancer Nursing, 2002
- Fatigue associated with cancer and its treatmentSupportive Care in Cancer, 2001
- Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2001
- Fatigue in cancerBMJ, 2001
- Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinomaBritish Journal of Cancer, 1999
- Fatigue and weakness in cancer patients: The symptom experienceSeminars in Oncology Nursing, 1995